Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Rain Oncology Inc. | President, Chief Scientific Officer | Common Stock, par value $0.001 per share | 0 | $0 | $1.21 | Jan 26, 2024 | Direct |
Rain Oncology Inc. | President, Chief Scientific Officer | Stock Option (Right to Buy) | 0 | Jan 26, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RAIN | Rain Oncology Inc. | Jan 26, 2024 | 13 | $0 | 4 | Jan 26, 2024 | President, Chief Scientific Officer |
RAIN | Rain Oncology Inc. | Aug 9, 2023 | 2 | $0 | 4 | Aug 11, 2023 | President, Chief Scientific Officer |
RAIN | Rain Oncology Inc. | Feb 15, 2023 | 1 | $0 | 4 | Feb 17, 2023 | President, Chief Scientific Officer |
RAIN | Rain Therapeutics Inc. | Jul 6, 2022 | 2 | $15.4K | 4 | Jul 7, 2022 | President, Chief Scientific Officer |
RAIN | Rain Therapeutics Inc. | Apr 13, 2022 | 2 | $11.9K | 4 | Apr 15, 2022 | President, Chief Scientific Officer |
RAIN | Rain Therapeutics Inc. | Mar 31, 2022 | 2 | $7.9K | 4 | Apr 4, 2022 | President, Chief Scientific Officer |
RAIN | Rain Therapeutics Inc. | Jan 7, 2022 | 1 | $0 | 4 | Feb 4, 2022 | EVP, Chief Scientific Officer |